ArticleCureus2026
Treatment Monitoring of Carpal Tunnel Syndrome Using Shear Wave Elastography: A Pilot In Vivo Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeShear wave elastography (SWE) is a non-invasive technique for assessing median nerve (MN) stiffness in carpal tunnel syndrome (CTS). This study evaluated whether SWE measurements of the MN improve after corticosteroid injection (CSI) and correlate with symptom improvement in CTS.
methodsTen patients (18 wrists) with CTS underwent SWE, grip strength testing, and completed questionnaires before and six weeks after ultrasound-guided CSI. SWE measurements included pressure and velocity in longitudinal/transverse planes at two locations: proximal to and at the carpal tunnel. Progression to carpal tunnel release (CTR) was recorded. Multivariate analyses assessed associations between SWE and symptom scores, controlling for confounders.
resultsFunctional Status Scale (FSS) and Symptom Severity Scale (SSS) scores improved post-injection (p=0.007 and p<0.001, respectively). Significant changes occurred in SWE carpal tunnel pressure and velocity (p<0.05). No significant association between SWE and CTR progression. Post-injection proximal MN pressure (p=0.005) and velocity (p=0.006) measured longitudinally were associated with FSS scores.
conclusionSWE measurements change with CSI but do not consistently predict symptom relief or surgery need. Questionnaires on daily function and symptoms may be more reliable for outcome tracking.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.